2000
DOI: 10.1159/000051557
|View full text |Cite
|
Sign up to set email alerts
|

Primary Cutaneous T-Cell-Rich B-Cell Lymphoma and Hodgkin’s Disease in a Patient with Gardner’s Syndrome

Abstract: A 50-year-old patient, suffering from familial polyposis (Gardner’s syndrome), initially presented with several nodules on his left arm. Histological examination revealed primary cutaneous T-cell-rich B-cell lymphoma (TCRBCL). Staging procedures failed to detect any systemic involvement. Three years after total excision of the tumours, the patient presented with a non-specific dermatitis, enlarged axillary lymph nodes and splenomegaly. Histological and immunohistochemical examination of lymph node and spleen b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2004
2004
2018
2018

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(2 citation statements)
references
References 9 publications
0
2
0
Order By: Relevance
“…Another possible explanation is hypothesized on the basis of tumor progression from lymphocyte-predominant Hodgkin’s disease, sharing common morphological features and supporting the recent evidence of hematopoietic plasticity in a single case of an acute B-lymphoblastic leukemia and Langerhans’ cell sarcoma [2,23]. Usually, lymphocyte-predominant Hodgkin’s lymphoma can also be differentiated by the lack of nodularity of the infiltrate, the absence of typical lymphohistiocytic cells, the large number of small B lymphocytes composing the nodules, the absence of CD57+ cells in the reactive infiltrate and the coexpression of CD15 and EMA in the blasts [2,11,17]. Differences between THRLBCL and lymphomatoid granulomatosis [24], an angiocentric variant of T-cell and/or histiocyte-rich B-cell monoclonal proliferation, are summarized in table 2.…”
Section: Discussionmentioning
confidence: 99%
“…Another possible explanation is hypothesized on the basis of tumor progression from lymphocyte-predominant Hodgkin’s disease, sharing common morphological features and supporting the recent evidence of hematopoietic plasticity in a single case of an acute B-lymphoblastic leukemia and Langerhans’ cell sarcoma [2,23]. Usually, lymphocyte-predominant Hodgkin’s lymphoma can also be differentiated by the lack of nodularity of the infiltrate, the absence of typical lymphohistiocytic cells, the large number of small B lymphocytes composing the nodules, the absence of CD57+ cells in the reactive infiltrate and the coexpression of CD15 and EMA in the blasts [2,11,17]. Differences between THRLBCL and lymphomatoid granulomatosis [24], an angiocentric variant of T-cell and/or histiocyte-rich B-cell monoclonal proliferation, are summarized in table 2.…”
Section: Discussionmentioning
confidence: 99%
“…14), CD22, and CD79a, with light‐chain restriction, but are negative for CD15 and CD30, which excludes Hodgkin lymphoma. The reactive small‐cell population represents T‐helper cells but small reactive B cells can also be found 190 . Due to the lower number of tumor cells, detection of IgH gene rearrangements may be difficult to assess in some cases.…”
Section: Who/eortc Classification For Cutaneous Lymphomasmentioning
confidence: 99%